Skip to content

APOTHEEK ARENA

Active Private limited companyfounded 1977active for 48 yearsHerentalsebaan 265, 2100 AntwerpKBO/BCE: BE 0417.781.176

Board

2 directors, no change since 2023
Director, permanent representative
appointed by deed of 30-10-2023
earlier manager, until 30-10-2023
listed in the 2025 annual accounts, filed on 17-07-2026
Director, permanent representative
appointed by deed of 30-10-2023
earlier manager, until 30-10-2023
listed in the 2025 annual accounts, filed on 17-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder.”
deed of 30-10-2023
Permanent representatives 2
Permanent representative, for
appointed by deed of 30-10-2023
Permanent representative, for
appointed by deed of 30-10-2023

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director

Director
BoardEarlier
Mandates as a list
    • Manager (not named in the articles), appointed by deed of 28-05-2015, until 30-10-2023
    • Director, appointed by deed of 30-10-2023, still in office
    • Manager (not named in the articles), appointed by deed of 28-05-2015, until 30-10-2023
    • Director, appointed by deed of 30-10-2023, still in office
With Starter you also see 2 former office holders in the mandate history. See the plans →

Control

Shareholder
Equity €433,946
Profit €87,947 in 2025 (profit €47,674 in 2024)
Checked score
50%
This company
APOTHEEK ARENA
Equity €95,574
Profit €31,972 in 2025

and 1 other shareholder

Capital

Contribution
€18,600
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
50%
50% until 2024
99% until 2014
Owners as a list
    • 2017 to 2025: 50%
    • 2017 to 2024: 50%
    • 2007 to 2011: 100%
    • 2012 to 2014: 99%

Source: lists of holdings in the owners' accounts

Articles of association

deed of 30-10-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Procedure- en expertisekosten voor helft ten laste overdrager en helft ten laste koper(s) naar evenredigheid verworven aantal aandelen als er meer dan één koper…
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Fourth Monday of May at 20:00

Shareholders

2 owners

Owners 2

  • Equity €433,946 Profit of €87,947 in 2025 (profit of €47,674 in 2024) Checked score
    Sourceaccounts 2025
    50%
  • Equity €296,073 Profit of €89,728 in 2025 (profit of €51,118 in 2024) Checked score
    Sourceaccounts 2025
    50%

Next steps